Better Space Stock to Buy With $2,000 and Hold for 10 Years: Rocket Lab vs. Joby Aviation

Rocket Lab reported record 2025 revenue of $602M (up 38% YoY), backlog of $1.85B (up 73%), a net loss of $198M, and >$1B in cash and marketable securities; its Neutron inaugural launch was delayed after a propellant tank failure but is now targeted for Q4 2026. Joby posted 2025 revenue of $53.4M, operating expenses of $773M and a net loss near $930M, with $1.4B in cash equivalents; it expects FAA type certification in 2026, plans to double production to 4 aircraft/month in 2027, and is acquiring an Ohio manufacturing facility. For a multi-year, risk-adjusted portfolio, Rocket Lab appears further along with substantial revenue and backlog, while Joby remains higher risk due to regulatory and cash-burn uncertainties despite strong demand indicators.

Analysis

The tactical contest is not just rocket vs. eVTOL — it’s who captures durable margin after the engineering risks are resolved. If Rocket Lab converts technical demonstrations into a predictable launch cadence, it can compress unit launch costs and force customers to re-evaluate long-term sourcing from incumbents; that will shift margin downstream to high-volume satellite assemblers and recurring-ops vendors rather than one-off vehicle sales. Conversely, Joby’s path is a regulatory-and-manufacturing arbitrage: certification unlocks revenue but also forces steep incremental capital spending to scale production and maintenance networks, meaning early revenue growth could be cash-flow negative for multiple years.

Key near-term signals to watch are operational, not just headlines: change in insured loss frequencies and premiums for launches/eVTOLs, supplier lead times for turbopumps and composite tooling, and production first-pass yield at new facilities. These metrics create asymmetric outcomes — a single sustained insurance-premium spike or multi-month supplier bottleneck will materially compress valuation multiples even if technology eventually works. For Joby, FAA-derived certification milestones are binary catalysts that compress option value into a narrow window; for Rocket Lab, cadence and backlog convertibility drive de-risking over a multi-quarter runway.

The market’s current pricing behaves like a binary-option auction for Joby and a mixed cash-flow multiple for Rocket Lab; that divergence creates a structured opportunity. If you believe operational execution will dominate regulatory headlines over 12–24 months, prefer instruments that capture multi-quarter upside while limiting downside during technical setbacks. Size positions to reflect asymmetric information risk: smaller, longer-dated option or spread exposure to regulatory-binary names and larger, more convex exposure to proven cadence names via call spreads or equity pairs.

Key Decisions for Investors

• Pair trade (6–12 months): Long RKLB equity (size X) / Short JOBY equity (size 0.6X) to express operational-progress over regulatory-binary risk. Use 20% stop-loss on the pair and trim at +40% realized vs entry; target asymmetric return ~2:1 if RKLB cadence improves while JOBY delays certification.
• RKLB options (12–18 months): Buy an RKLB 12-month call spread (buy nearer-term ATM call, sell higher-strike call 1.2–1.5x) to capture technology/de-risking upside with defined capital at risk. Expect 2–3x payoff if launch cadence and margin talk convert; maximum loss = net premium paid.
• JOBY hedges (9–12 months): Buy a JOBY put spread (debit vertical) to protect against certification delay/dilution risk while keeping premium limited. Structure to lose only premium (max loss) and target 3:1 payoff if certification slips or capital raise erodes equity.
• Tactical defense/supplier hedge (12 months): Long selective defense primes or composite/turbopump suppliers (size moderate) to capture re-sourcing and supply-chain win if launch competition intensifies. Use trailing stop at 15% profit and reassess on supplier lead-time improvements; asymmetric upside if procurement shifts.